<code id='0233B14429'></code><style id='0233B14429'></style>
    • <acronym id='0233B14429'></acronym>
      <center id='0233B14429'><center id='0233B14429'><tfoot id='0233B14429'></tfoot></center><abbr id='0233B14429'><dir id='0233B14429'><tfoot id='0233B14429'></tfoot><noframes id='0233B14429'>

    • <optgroup id='0233B14429'><strike id='0233B14429'><sup id='0233B14429'></sup></strike><code id='0233B14429'></code></optgroup>
        1. <b id='0233B14429'><label id='0233B14429'><select id='0233B14429'><dt id='0233B14429'><span id='0233B14429'></span></dt></select></label></b><u id='0233B14429'></u>
          <i id='0233B14429'><strike id='0233B14429'><tt id='0233B14429'><pre id='0233B14429'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:8834
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          STAT Virtual Event: ASCO Recap, Live!
          STAT Virtual Event: ASCO Recap, Live!

          Editor’snote:Alivestreamoftheeventwillbeembeddedbelowat1p.m.ET.STAT’sreporters,strung-outfromseveral

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Stephen Quake on the Chan Zuckerberg quest to conquer disease

          StephenQuake:"OurNorthStarforthenextdecadeisunderstandingthemysteriesofthecell."ChanZuckerbergInitia